We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hemogenyx Pharmaceuticals Plc | LSE:HEMO | London | Ordinary Share | GB00BYX3WZ24 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.002 | 0.13% | 1.567 | 1.536 | 1.598 | 1.55 | 1.538 | 1.55 | 4,833,427 | 16:35:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.98M | -0.0035 | -4.40 | 17.59M |
Date | Subject | Author | Discuss |
---|---|---|---|
06/3/2018 11:00 | I’d say stig is spot on. 4.14 to sell. Not much interest except from people who bought and failed to sell on the spike. | sidjameslaugh | |
06/3/2018 10:59 | Plummeting again. All the way back to 2p. | lodgeview | |
06/3/2018 10:16 | Stig - sounding increasingly desperate. | tsmith2 | |
06/3/2018 09:11 | Hemo like sending RNS's and like above, I think more good news is due very soon indeed. It would not surprise me if we hear of " game changing" news in the next week or two. Dr Sheppard has been recruited for a reason and is associated with good Companies. He would not have joined unless it boots his reputation. | ernestsyngen | |
06/3/2018 08:36 | yep, to me that is the true great news | the patient investor | |
06/3/2018 08:35 | And he's sold on a string of embryo companies to majors, in the past. | andrbea | |
06/3/2018 08:34 | also, the timing of his involvement must mean something is brewing and we may be close to further great news, you don't involve such a great figure just like that. There is definitely something round the corner. Often good RNSs lead to even better ones. | the patient investor | |
06/3/2018 08:32 | Dr Shepard is a superb name for Hemo to have working for them. He knows this business very well indeed. | ernestsyngen | |
06/3/2018 08:31 | thanks hattie1 I am a former scientist in a very different field (bacteria in plant pathology) and I often used to see great minds who sadly had limited business acumen and a disconnection with the industry. This guy seems to have both a great brain and business intelligence in large amounts! Meanwhile the MMs are playing their usual games scaring people as they certainly expect a huge demand for this share which, good for us, is very very illiquid. I can easily see 10p in a few months. | the patient investor | |
06/3/2018 08:24 | As a former Oncology nurse I'm very impressed at this appointment especially as Dr Shepard was involved with herceptin which has massive benefits for breast cancer patients ... | hattie1 | |
06/3/2018 08:18 | nor is 3p by the looks of it! | 113mike | |
06/3/2018 08:12 | this is much more remarkable than it seems. this guy is not just a top scientist but somebody who helped creating multibillion selling new cutting edge drugs. He has already all the right contacts in the industry. To me this RNS is worth in itself 2-3p at least. I am not saying it is as if a small IT company had acquired the combined services of Steve Jobs and Steve Wozniak but the comparison is not too far away. this will make our tiny company super attractive to the big pharmas 10p is not far | the patient investor | |
06/3/2018 07:48 | Great news. Onwards and upwards! | cudmore | |
06/3/2018 07:31 | Commenting Dr. Shepard, said: "Hemogenyx is developing cancer therapies that have the potential to save lives, and I'm proud to be a part of that. As a member of Hemogenyx's Scientific Advisory Board, I'll be able to use the experience I've accrued working with other pre-clinical biotechnology programmes to help guide Hemogenyx toward the release of successful antibody-based therapies." | orchestralis | |
05/3/2018 22:52 | Oh they are, they really are. | lufc5 | |
05/3/2018 21:16 | humanised mice alone must be worth a bomb | buddugoliaeth | |
05/3/2018 20:37 | This will do a VAL. A long way off any realisation of value, will shortly be back at 3p. | rathean | |
05/3/2018 15:34 | Tax you any way they can but a profit is still a profit! | ernestsyngen | |
05/3/2018 13:56 | same here! i detest it | the patient investor | |
05/3/2018 13:39 | Never knew you had to pay stamp duty buying this one but you do. Hate doing that. So either I hold for a while or next I sell I will just not trade it again. One of my pet hates paying stamp duty on stocks now | dave4545 | |
05/3/2018 13:37 | cudmore can you post link to broker note please thx or just post a brief summary | the patient investor | |
05/3/2018 13:28 | I tired to buy on the drop but no chance whatsoever!!!! | billthebank | |
05/3/2018 13:24 | Buyers getting on board now realising they are still way too cheap when you look at the realistic price these are worth | cudmore |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions